Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Portal hypertension in non-alcoholic fatty liver disease (NAFLD) can occur early due to lipid accumulation, not just fibrosis. Current diagnostic methods may underestimate pressure, necessitating new approaches for accurate risk assessment.
Area Of Science
- Hepatology
- Gastroenterology
- Pathophysiology
Background
- Portal hypertension (PH) is traditionally linked to advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
- Emerging evidence suggests PH can develop in earlier NAFLD stages through mechanisms beyond fibrosis.
- Hepatocellular lipid accumulation and ballooning contribute to sinusoidal compression and early PH.
Purpose Of The Study
- To explore the early pathogenetic mechanisms of portal hypertension in non-alcoholic fatty liver disease.
- To address the limitations of current diagnostic methods in accurately assessing portal pressure in NAFLD.
- To identify reliable methods for prognostic risk stratification in NAFLD patients with portal hypertension.
Main Methods
- Review of recent studies on NAFLD pathogenesis and portal hypertension.
- Analysis of histological and functional changes in liver lobules.
- Evaluation of diagnostic methods including hepatic venous pressure gradient (HVPG) and non-invasive markers.
Main Results
- Early PH in NAFLD is associated with hepatocellular lipid accumulation, ballooning, and sinusoidal compression.
- Mechanotransduction pathways activated by mechanical forces contribute to endothelial dysfunction and fibrosis.
- Current methods like HVPG may underestimate portal pressure in NAFLD, potentially missing clinically significant portal hypertension (CSPH).
Conclusions
- NAFLD-associated PH involves mechanisms beyond fibrosis, including lipid accumulation and mechanical stress.
- Accurate diagnosis and risk stratification of PH in NAFLD are challenging due to limitations in current methods.
- Non-invasive methods like liver/spleen stiffness and platelet count show promise for diagnosing CSPH; lifestyle changes and metabolic syndrome management are key treatments.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Detailed History: Understanding the patient's symptoms is critical. It includes inquiring about abdominal pain, weight loss, and digestive issues, which are common in chronic pancreatitis.
Physical Examination: This might reveal abdominal tenderness, jaundice, and signs of malnutrition,...
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Technological Integration: EUS is a sophisticated integration of optical endoscopy and ultrasonography. The endoscope visualizes the mucosal surface directly, while the ultrasound component penetrates deeper to visualize organs and structures beyond the gastrointestinal wall.
Image Formation: The ultrasound...